India’s Lupin gets FDA nod to make generic oral contraceptive
HQ Team August 2, 2023: India’s Lupin Ltd., the eighth largest generic pharmaceutical company in the world based on revenue, has received the.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
HQ Team August 2, 2023: India’s Lupin Ltd., the eighth largest generic pharmaceutical company in the world based on revenue, has received the.
Lupin Digital Health, a fully-owned subsidiary of Lupin, stated 83.3% of study patients with the acute coronary syndrome (ACS) maintained their vital signs.
Lupin Limited, an Indian maker of branded, generic formulations, biotechnology products, and active pharmaceutical ingredients, has got USFDA approval for its ANDA injection,.
Pharma major Lupin has received a ‘tentative approval’, from the United States Food and Drug Administration (FDA), to market medicines used to treat.
Lupin buys two inhalation brands for $75million
September 22, 2022: Lupin Ltd., one of the top Indian pharmaceutical majors, has received approval from the US drug regulator United States Food.